Pharmacoepidemiology and Drug Safety

Cover image for Vol. 20 Issue 7

July 2011

Volume 20, Issue 7

Pages 675–783

  1. Commentaries

    1. Top of page
    2. Commentaries
    3. Brief Reports
    4. Original Reports
    5. Commentaries
    6. Reviews
    7. Original Reports
    8. Letters to the Editor
  2. Brief Reports

    1. Top of page
    2. Commentaries
    3. Brief Reports
    4. Original Reports
    5. Commentaries
    6. Reviews
    7. Original Reports
    8. Letters to the Editor
    1. Utilizing Medicare claims data for real-time drug safety evaluations: is it feasible? (pages 684–688)

      Abraham G. Hartzema, Judith A. Racoosin, Thomas E. MaCurdy, Jonathan M. Gibbs and Jeffrey A. Kelman

      Version of Record online: 27 MAY 2011 | DOI: 10.1002/pds.2143

  3. Original Reports

    1. Top of page
    2. Commentaries
    3. Brief Reports
    4. Original Reports
    5. Commentaries
    6. Reviews
    7. Original Reports
    8. Letters to the Editor
    1. Validity of diagnostic codes and liver-related laboratory abnormalities to identify hepatic decompensation events in the Veterans Aging Cohort Study (pages 689–699)

      Vincent Lo Re III, Joseph K. Lim, Matthew Bidwell Goetz, Janet Tate, Harini Bathulapalli, Marina B. Klein, David Rimland, Maria C. Rodriguez-Barradas, Adeel A. Butt, Cynthia L. Gibert, Sheldon T. Brown, Farah Kidwai, Cynthia Brandt, Zachariah Dorey-Stein, K. Rajender Reddy and Amy C. Justice

      Version of Record online: 27 MAY 2011 | DOI: 10.1002/pds.2148

    2. Validity of claims-based definitions of left ventricular systolic dysfunction in Medicare patients (pages 700–708)

      Qian Li, Robert J. Glynn, Nancy A. Dreyer, Jun Liu, Helen Mogun and Soko Setoguchi

      Version of Record online: 14 MAY 2011 | DOI: 10.1002/pds.2146

    3. Accuracy of identifying neutropenia diagnoses in outpatient claims data (pages 709–713)

      Seo Young Kim, Daniel H. Solomon, Jun Liu, Chun-Lan Chang, Gregory W. Daniel and Sebastian Schneeweiss

      Version of Record online: 12 MAY 2011 | DOI: 10.1002/pds.2157

  4. Commentaries

    1. Top of page
    2. Commentaries
    3. Brief Reports
    4. Original Reports
    5. Commentaries
    6. Reviews
    7. Original Reports
    8. Letters to the Editor
    1. Safety surveillance of longitudinal databases: methodological considerations (pages 714–717)

      G. Niklas Norén, Johan Hopstadius, Andrew Bate and I. Ralph Edwards

      Version of Record online: 2 JUN 2011 | DOI: 10.1002/pds.2151

  5. Reviews

    1. Top of page
    2. Commentaries
    3. Brief Reports
    4. Original Reports
    5. Commentaries
    6. Reviews
    7. Original Reports
    8. Letters to the Editor
    1. Systematic review of peptic ulcer disease incidence rates: do studies without validation provide reliable estimates? (pages 718–728)

      Kueiyu Joshua Lin, Luis A. García Rodríguez and Sonia Hernández-Díaz

      Version of Record online: 27 MAY 2011 | DOI: 10.1002/pds.2153

  6. Original Reports

    1. Top of page
    2. Commentaries
    3. Brief Reports
    4. Original Reports
    5. Commentaries
    6. Reviews
    7. Original Reports
    8. Letters to the Editor
    1. Nationwide register-based surveillance system on drugs and pregnancy in Finland 1996–2006 (pages 729–738)

      Miia Artama, Mika Gissler, Heli Malm and Annukka Ritvanen

      Version of Record online: 27 MAY 2011 | DOI: 10.1002/pds.2159

    2. Effects of pharmaceutical counselling on antimicrobial use in surgical wards: intervention study with historical control group (pages 739–746)

      Eva Grill, Alexandra Weber, Stefanie Lohmann, Cornelia Vetter-Kerkhoff, Ralf Strobl and Karl-Walter Jauch

      Version of Record online: 30 MAR 2011 | DOI: 10.1002/pds.2126

    3. Life-threatening drug-associated hyperkalemia: a retrospective study from laboratory signals (pages 747–753)

      Pernelle Noize, Haleh Bagheri, Geneviève Durrieu, Françoise Haramburu, Nicholas Moore, Patrick Giraud, Michel Galinier, Jacques Pourrat and Jean-Louis Montastruc

      Version of Record online: 16 MAR 2011 | DOI: 10.1002/pds.2128

    4. Coronary heart disease outcomes among chronic opioid and cyclooxygenase-2 users compared with a general population cohort (pages 754–762)

      Wendy J. Carman, Shuhua Su, Suzanne F. Cook, John I. Wurzelmann and Andrew McAfee

      Version of Record online: 12 MAY 2011 | DOI: 10.1002/pds.2131

    5. Market withdrawal of new molecular entities approved in the United States from 1980 to 2009 (pages 772–777)

      Zaina P. Qureshi, Enrique Seoane-Vazquez, Rosa Rodriguez-Monguio, Kurt B. Stevenson and Sheryl L. Szeinbach

      Version of Record online: 14 MAY 2011 | DOI: 10.1002/pds.2155

  7. Letters to the Editor

    1. Top of page
    2. Commentaries
    3. Brief Reports
    4. Original Reports
    5. Commentaries
    6. Reviews
    7. Original Reports
    8. Letters to the Editor

SEARCH

SEARCH BY CITATION